Cat.#: ASSD-140
Description | A2B covalent ligand selectively targets lysine residue(s) on the receptor and binds persistently in radioligand displacement and wash-out assays, allowing for novel ways to interrogate the A2BAR. Apparent pKi values at A2BARs are 8.10 and 9.17 (after 4h), where a Ki shift indicates a covalent mode of action. Displays ~100 -fold selectivity for A2B compared to A1, A2A and A3 receptors. |
Size | 50 μg |
Chemical Name | 4-(2,6-dioxo-1-propyl-2,3,6,7-tetrahydro-1H-purin-8-yl)benzenesulfonyl fluoride |
Molecule Weight | 352.3 |
Molecular formula | C14H13FN4O4S |
Purity | >95% |
Solubility | Soluble in DMSO |
Storage | Store at -20° C |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ASSD-137 | CCR2 covalent NAM (AC137) | 50 μg | inquiry |
ASSD-112 | Propidium Iodide Staining Solution (1mg/ml) in water (AC112) | 1 mL | inquiry |
ASSD-105 | Hoechst 33342 (AC105) | 10 mg, 100 mg | inquiry |
ASSD-171 | Ionomycin calcium salt (AC171) | 1mg, 5mg | inquiry |
ASSD-150 | Luminol (AC150) | 1 g | inquiry |
ASSD-209 | Tetramethylrhodamine isothiocyanate Isomer R (AC209) | 5 mg, 10 mg | inquiry |
ASSD-158 | Eosin Y (AC158) | 1g | inquiry |
ASSD-122 | Fluorescent β2 antagonist [(±)-propranolol] (AC122) | 500 μg | inquiry |
ASSD-181 | Nitrofluorescein, Isomer 1 (AC181) | 1 g | inquiry |
ASSD-156 | Crystal Violet (AC156) | 1g, 5g | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.